BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21403614)

  • 1. Multifactorial nature of tumor drug resistance.
    Solyanik GI
    Exp Oncol; 2010 Sep; 32(3):181-5. PubMed ID: 21403614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.
    Tomida A; Tsuruo T
    Anticancer Drug Des; 1999 Apr; 14(2):169-77. PubMed ID: 10405643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of tumor cell chemoresistance mechanisms.
    Gatti L; Zunino F
    Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research advance on role of tumor microenvironment in mediating acquired drug resistance].
    Ma XL; Xing H; Ma D
    Ai Zheng; 2007 Aug; 26(8):923-6. PubMed ID: 17697561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug penetration in solid tumours.
    Minchinton AI; Tannock IF
    Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why chemotherapy can fail?
    Król M; Pawłowski KM; Majchrzak K; Szyszko K; Motyl T
    Pol J Vet Sci; 2010; 13(2):399-406. PubMed ID: 20731201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.
    Damaraju VL; Damaraju S; Young JD; Baldwin SA; Mackey J; Sawyer MB; Cass CE
    Oncogene; 2003 Oct; 22(47):7524-36. PubMed ID: 14576856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.
    Hazlehurst LA; Landowski TH; Dalton WS
    Oncogene; 2003 Oct; 22(47):7396-402. PubMed ID: 14576847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to chemotherapy in cancer: a complex and integrated cellular response.
    Mellor HR; Callaghan R
    Pharmacology; 2008; 81(4):275-300. PubMed ID: 18259091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance and the solid tumor microenvironment.
    Trédan O; Galmarini CM; Patel K; Tannock IF
    J Natl Cancer Inst; 2007 Oct; 99(19):1441-54. PubMed ID: 17895480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs.
    Onozuka H; Tsuchihara K; Esumi H
    Cancer Sci; 2011 May; 102(5):975-82. PubMed ID: 21255190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-D tumor model for in vitro evaluation of anticancer drugs.
    Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
    Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to antineoplastic treatments: mechanisms, clinical value].
    Bonnal C; Calvo F
    C R Seances Soc Biol Fil; 1996; 190(4):455-66. PubMed ID: 8952896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in cancer therapy: role of the microenvironment.
    Galmarini CM; Galmarini FC
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.